Venture
NiKang Therapeutics, Inc.
Latest Form D 2021-06-07- CIK 1864608
- State DE
- Biotechnology
- 1 Form D offering since 2021-06-07
- Total sold
- $200M
- across its one offering
- Rounds
- 1
- Form D offerings since 2021-06-07
- Latest round
- $200M
- 2021-06-07 · 021-401881
- Investors
- 30
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-06-071 Form D offeringExemptions506(b)People · Item 3Zhenhai Gao + 7 moreInvestors · dashboardInferred investors
NiKang Therapeutics, Inc.CIK 1864608
Round timeline
amount sold · by first filed2021-06-07 · $200M
- 2021-06-07$200M021-401881
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($200M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-401881 | First filed2021-06-07 | Latest2021-06-07 | Sought$200M | Sold$200M | Investors30 | Exemptions506(b) |
Who backs NiKang Therapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-06-07
| Name | Relationship | Clarification |
|---|---|---|
| Zhenhai Gao | RelationshipExecutive Officer, Director | ClarificationPresident, CEO, and Secretary |
| Hong (Kelsey) Chen | RelationshipExecutive Officer | ClarificationChief Financial Officer |
| Roderick Wong | RelationshipDirector | Clarification— |
| Sean Cao | RelationshipDirector | Clarification— |
| Wei Fu | RelationshipDirector | Clarification— |
| Gary Yeung | RelationshipDirector | Clarification— |
| Ting Jia | RelationshipDirector | Clarification— |
| Zhengbin Yao | RelationshipDirector | Clarification— |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Delaware (DE)
- Exemptions
- Rule 506(b)
- First filed
- 2021-06-07
- Latest filing
- 2021-06-07
Who backs NiKang Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗